atrial fibrillation
Conditions
Interventions
Radiofrequency ablation group:RF ablation treatment
Second generation cryoballoon ablation group:2G-CB ablation treatment
Sponsors
The First Affiliated Hospital of Xinjiang Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) patients diagnosed with atrial fibrillation after implantation of a pacemaker (atrial fibrillation burden 1-50%); (2) with pacemaker indications and pacemakers have recording ability; (3) patients must use warfarin or NOAC; (4) Aged 18-75 years old; (5) the patient provided informed consent prior to participating in the study.
Exclusion criteria
Exclusion criteria: (1) left atrial diameter > 50mm or left atrial thrombosis; (2) history of previous atrial fibrillation ablation; (3) unstable angina < 1 week or acute myocardial infarction < 6 months; (4) cardiac surgery < 2 Months; (5) patients are participating in other clinical studies; (6) chronic heart failure (NYHA III / IV); (7) pregnancy; (8) patients with other types of arrhythmia; (9) history of neurological or psychiatric disorders; (10) GFR <40 ml/min; (11) shortened life expectancy (< 1 year); (12) unwilling to adhere to treatment or unwilling to sign treatment informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Burden of AF;Types and numbers of major adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| LVEF;Left atrial diameter; | — |
Countries
China
Contacts
Public ContactYaodong Li
Department of Pacing and Electrophysiology, The First Affiliated Hospital of Xinjiang Medical University
Outcome results
None listed